FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24
In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced
DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program
FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA
NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - Imaging’s ride to the bottom in clinical trials—and why it matters now
- NIH says it’s moving away from animal-based models
- The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic - ODAC nixes GSK’s Blenrep myeloma regimens, citing ocular toxicity, dosing, applicability to U.S. population